BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22402725)

  • 1. [Effect of levetiracetam on intractable secondarily generalized seizure and depression].
    Hayashi T; Inoue K; Shinoda J
    Brain Nerve; 2012 Mar; 64(3):303-7. PubMed ID: 22402725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure risk in brain tumor patients with conversion to generic levetiracetam.
    Armstrong TS; Choi S; Walker J; Gilbert MR
    J Neurooncol; 2010 May; 98(1):137-41. PubMed ID: 19936624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam: preliminary efficacy in generalized seizures.
    Kasteleijn-Nolst Trenité DG; Hirsch E
    Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brand name to generic substitution of levetiracetam in patients with epilepsy.
    Gha-Hyun L; Dae SJ
    Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.
    Russo E; Citraro R; Scicchitano F; De Fazio S; Perrotta I; Di Paola ED; Constanti A; De Sarro G
    Epilepsia; 2011 Jul; 52(7):1341-50. PubMed ID: 21635238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probable levetiracetam-associated depression in the elderly: two case reports.
    Vande Griend JP; Linnebur SA; Bainbridge JL
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):281-4. PubMed ID: 19948304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
    Ishii Y; Tanaka T
    Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D; French JA
    Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin or levetiracetam for seizure prophylaxis in TBI.
    DeDea L
    JAAPA; 2012 Dec; 25(12):11. PubMed ID: 23599996
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in children and adolescents with epilepsy and hemiplegic cerebral palsy.
    Harbord MG
    J Paediatr Child Health; 2011 May; 47(5):302-4. PubMed ID: 21244554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
    Cavitt J; Privitera M
    Arch Neurol; 2004 Oct; 61(10):1604-7. PubMed ID: 15477517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD; Huff AD; Knupp KG; Valuck RJ
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
    Murray-Brown FL; Stewart A
    BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
    [No Abstract]   [Full Text] [Related]  

  • 15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic substitution of levetiracetam resulting in increased incidence of breakthrough seizures.
    Fitzgerald CL; Jacobson MP
    Ann Pharmacother; 2011 May; 45(5):e27. PubMed ID: 21521860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Donato Di Paola E; Gareri P; Davoli A; Gratteri S; Scicchitano F; Naccari C; De Sarro G
    Epilepsy Res; 2007 Jul; 75(2-3):112-21. PubMed ID: 17553669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.